Completed
Safety And Immunogenicity Of Novel Candidate Blood-Stage Malaria Vaccine P27A : Phase Ia/Ib
NCT01949909
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- CHUV CRC Lausanne, Switzerland
- Bagamoyo Clinical Trial Unit (BCTU) Bagamoyo, Tanzania